MAPT and Alzheimer disease: Similarly in a longitudinal study for patients with MCI, Hansson et al. have demonstrated that CSF amyloid and/or tau concentrations have predictive value for progression to AD, where CSF measures show limited specificity (Hansson et al., 2006).